BioCision Receives $2,500,000 New Funding

  • Feed Type
  • Date
    12/6/2012
  • Company Name
    BioCision
  • Mailing Address
    12 East Sir Francis Drake Blvd Larkspur, CA 94939
  • Company Description
    Our mission is to standardize pre-analytical sample handling. We develop and provide products that eliminate variability in common, often-overlooked, laboratory procedures. Our product lines are marketed globally through an extensive distributor network and have been readily adopted by the leading institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community.
  • Website
    http://www.biocision.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Funding will be used to support the company’s continued rapid growth and expansion of sales, marketing and product development efforts.
  • M&A Terms
  • Venture Investor
    BroadOak Capital Partners
  • Venture Investor
    RCT BioVentures

By posting a comment, you agree to our terms and conditions.